Introduction to Fl Switching To Bendamustine Rituximab At Progression
Let's dive into the details surrounding Fl Switching To Bendamustine Rituximab At Progression. Peter Martin, MD, evaluates the decision to treat a patient with
Fl Switching To Bendamustine Rituximab At Progression Comprehensive Overview
Joshua Brody, The Tisch Cancer Institute at Mount Sinai, New York City, NY, discusses initial findings from the EPCORE NHL-2 ... Mathias Rummel, MD, PhD from Justus Liebig University, Giessen, Germany gives us an update the study of Stefano Luminari, MD, University of Modena and Reggio Emilia, Modena, Italy, describes the effect of immuno-chemotherapy in ...
Loretta Nastoupil, MD, University of Texas MD Anderson Center, Houston, TX, discusses a retrospective study aiming to examine ...
Summary & Highlights for Fl Switching To Bendamustine Rituximab At Progression
- Dr. Burke, on whether
- Suzanne Arulogun, MBBS, FRACP, FRCPA, University College London Hospitals NHS Foundation Trust, London, UK, shares the ...
- Peter Martin, MD, reflects upon the decision to treat high-risk
- For patients with non-Hodgkin lymphomas,
- ... in that particular abstract what the investigators were looking at was overall responses and
That wraps up our extensive overview of Fl Switching To Bendamustine Rituximab At Progression.